GRIEGO, ANNA
GRIEGO, ANNA
Dipartimento di Scienze Farmaceutiche
Nanoparticle delivery through the BBB in central nervous system tuberculosis
2023 A. Griego, E. Scarpa, V. De Matteis, L. Rizzello
Preexisting variation in DNA damage response predicts the fate of single mycobacteria under stress
2019 G. Manina, A. Griego, L. Kumar Singh, J. D McKinney, N. Dhar
RNase E and HupB dynamics foster mycobacterial cell homeostasis and fitness
2022 A. Griego, G. Manina, T. Douché, Q. Gia Giannetto, M. Matondo
Size Effect of Silver Nanoparticles Derived from Olive Mill Wastewater in THP-1 Cell Lines
2023 V. De Matteis, A. Griego, E. Scarpa, M. Cascione, J. Singh, L. Rizzello
Synthesis and Assessment of the In Vitro and Ex Vivo Activity of Salicylate Synthase (Mbti) Inhibitors as New Candidates for the Treatment of Mycobacterial Infections
2022 M. Mori, G. Stelitano, A. Griego, L.R. Chiarelli, G. Cazzaniga, A. Gelain, E. Pini, M. Camera, P. Canzano, A. Fumagalli, E. Scarpa, C. Cordiglieri, L. Rizzello, S. Villa, F. Meneghetti
Targeting Siderophore-Mediated Iron Uptake in M. abscessus: A New Strategy to Limit the Virulence of Non-Tuberculous Mycobacteria
2023 M. Mori, G. Stelitano, G. Cazzaniga, A. Gelain, A. Tresoldi, M. Cocorullo, M. Roversi, L.R. Chiarelli, M. Tomaiuolo, P. Delre, G. Felice Mangiatordi, A. Griego, L. Rizzello, A. Cassetta, S. Covaceuszach, S. Villa, F. Meneghetti
Targeting the mycobactin biosynthesis pathway in M. tuberculosis: a step towards the improvement of the anti-virulence activity of MbtI inhibitors
2022 M. Mori, S. Villa, L.R. Chiarelli, G. Stelitano, A. Gelain, G. Cazzaniga, M. Bellinzoni, L. Rizzello, E. Scarpa, A. Griego, A. Fumagalli, F. Meneghetti
Wnt/Tcf1 pathway restricts embryonic stem cell cycle through activation of the Ink4/Arf locus
2017 A. De Jaime-Soguero, F. Aulicino, G. Ertaylan, A. Griego, A. Cerrato, A. Tallam, A. del Sol, M. Pia Cosma, F. Lluis